LEADER 04113nam 2200613 a 450 001 9910454776603321 005 20200520144314.0 010 $a90-6299-849-6 035 $a(CKB)1000000000773964 035 $a(EBL)449440 035 $a(OCoLC)609842303 035 $a(SSID)ssj0000360573 035 $a(PQKBManifestationID)12111113 035 $a(PQKBTitleCode)TC0000360573 035 $a(PQKBWorkID)10344288 035 $a(PQKB)11586480 035 $a(MiAaPQ)EBC449440 035 $a(Au-PeEL)EBL449440 035 $a(CaPaEBR)ebr10505624 035 $a(EXLCZ)991000000000773964 100 $a20111129d2008 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aGlaucoma screening$b[electronic resource] $escreening for open angle glaucoma, primary angle-closure and primary angle-closure glaucoma : the 5th consensus report of the World Glaucoma Association /$fedited by Robert N. Weinreb, Paul R. Healey and Fotis Topouzis 210 $aAmsterdam, The Netherlands $cKugler Publications$d[2008] 215 $a1 online resource (165 p.) 225 1 $aConsensus series ;$v5 300 $aDescription based upon print version of record. 311 $a90-6299-218-8 320 $aIncludes bibliographical references and index. 327 $aFACULTY; CONTENTS; PREFACE; WELCOME; SCREENING FOR OPEN-ANGLE GLAUCOMA (OAG); IS OAG AN IMPORTANT HEALTH; IS THERE AN ACCEPTED AND EFFECTIVE TREATMENT FOR PATIENTS WITH THE DISEASE THAT IS MORE EFFECTIVE AT PREVENTING MORBIDITY WHEN INITIATED IN THE EARLY, ASYMPTOMATIC STAGE THAN WHEN BEGUN IN THE LATER,; ARE FACILITIES FOR DIAGNOSIS AND TREATMENT AVAILABLE?; IS THERE AN APPROPRIATE, ACCEPTABLE, AND REASONABLY ACCURATE SCREENING TEST?; IS THE NATURAL HISTORY OF THE CONDITION, INCLUDING DEVELOPMENT FROM LATENT TO MANIFEST DISEASE, ADEQUATELY UNDERSTOOD? 327 $aIS THE COST OF CASE FINDING (INCLUDING DIAGNOSIS AND TREATMENT OF PATIENTS DIAGNOSED) ECONOMICALLY BALANCED IN RELATION TO POSSIBLE EXPENDITURE ON MEDICAL CARE AS A WHOLE?SCREENING FOR PRIMARY ANGLE CLOSURE AND PRIMARY ANGLE-CLOSURE GLAUCOMA; ARE ANGLE CLOSURE (AC) AND ANGLE-CLOSURE GLAUCOMA (ACG) IMPORTANT HEALTH PROBLEMS?; IS THERE AN ACCEPTED AND EFFECTIVE TREATMENT FOR PATIENTS WITH ANGLE-CLOSURE GLAUCOMA (ACG) THAT IS MORE EFFECTIVE AT PREVENTING MORBIDITY WHEN INITIATED IN THE EARLY, ASYMPTOMATIC STAGE THAN WHEN BEG; ARE FACILITIES FOR DIAGNOSIS AND TREATMENT AVAILABLE? 327 $aIS THERE AN APPROPRIATE, ACCEPTABLE, AND REASONABLY ACCURATE SCREENING TEST?IS THE NATURAL HISTORY OF THE CONDITION, INCLUDING DEVELOPMENT FROM LATENT TO MANIFEST DISEASE, ADEQUATELY UNDERSTOOD?; IS THE COST OF CASE FINDING (INCLUDING DIAGNOSIS AND TREATMENT OF PATIENTS DIAGNOSED) ECONOMICALLY BALANCED IN RELATION TO POSSIBLE EXPENDITURE ON MEDICAL CARE AS A WHOLE?; INDEX OF AUTHORS; SUMMARY CONSENSUS POINTS 330 $aThis is the fifth glaucoma World Glaucoma Association Consensus. As with other consensus topics, the discussion and conclusions of Glaucoma Screening, the subject for the 2008 consensus, will have broad impact. The global faculty, consisting of leading authorities on various aspects of glaucoma screening, met in Fort Lauderdale on April 26, 2008 to discuss the reports and refine the consensus statements. The Consensus Panel also met at that time, as well as electronically during the subsequent four weeks.Obtaining consensus on how best to conduct glaucoma screening is quite a challenge, especi 410 0$aConsensus series (World Glaucoma Association) ;$v5. 606 $aGlaucoma$xDiagnosis 608 $aElectronic books. 615 0$aGlaucoma$xDiagnosis. 676 $a617.7/41 676 $a617.741 701 $aWeinreb$b Robert N.$f1949-$0862806 701 $aHealey$b Paul R$0962613 701 $aTopouzis$b Fotis$0962614 712 02$aWorld Glaucoma Association. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910454776603321 996 $aGlaucoma screening$92182771 997 $aUNINA